FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00066638 · COMPLETED

Trial details

NCT number: NCT00066638
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2003-06-01
Primary completion: 2007-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.